Vapi, Abu Dhabi Investment Authority (ADIA) has confirmed an investment of $200 million for approximately a 3% stake in Micro Life Sciences Private Limited (Meril). This investment will value Meril at $6.6 billion. The transaction is subject to approval by the Competition Commission of India (CCI).
Established by the Bilakhia Group, Meril is an Indian medical devices company providing clinically advanced solutions in various fields, including cardiovascular, orthopedics, surgical robotics, and in-vitro diagnostics. Its headquarters are located in Vapi.
Meril operates from a 100-acre green energy-based MedTech campus, featuring state-of-the-art manufacturing, research, clinical, and development facilities. The company has over 35 global subsidiaries and serves healthcare systems in more than 150 countries.
Meril’s key technological achievements include the MyVal Transcatheter Heart Valve (THV) series, MyClip TEER system, and MISSO surgical robotic system. Through its 12+ global training academies, the company trains over 10,000 healthcare professionals annually.
Also Read:
Meril’s Senior Vice President (Strategy) stated, “ADIA’s investment reflects confidence in Meril’s long-term vision and global ambitions. This will help us accelerate growth, attract global talent, and strengthen our R&D efforts.”
Vapi
Vapi is a city in the Indian state of Gujarat, located near the border of Maharashtra. Historically, it has been an industrial hub, known for its chemical and pharmaceutical industries since the late 20th century. The city’s growth was fueled by its strategic location along the Mumbai-Delhi industrial corridor.
Abu Dhabi Investment Authority (ADIA)
The Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund established in 1976 by the government of Abu Dhabi to manage the emirate’s surplus oil revenues and diversify its economy. With a focus on long-term global investments across various asset classes, ADIA plays a key role in securing Abu Dhabi’s financial future. Though its exact assets are undisclosed, it is one of the world’s largest sovereign wealth funds, reflecting Abu Dhabi’s strategic economic vision.
Micro Life Sciences Private Limited (Meril)
Micro Life Sciences Private Limited, operating under the brand Meril, is an Indian multinational medical technology company founded in 2006. Headquartered in Vapi, Gujarat, Meril specializes in manufacturing innovative medical devices, including cardiovascular implants, surgical equipment, and diagnostic solutions. The company is known for its research-driven approach and has expanded globally, contributing to advancements in minimally invasive healthcare technologies.
Competition Commission of India (CCI)
The **Competition Commission of India (CCI)** is a statutory body established in 2003 under the *Competition Act, 2002* to promote fair competition, prevent anti-competitive practices, and protect consumer interests in India. It became fully functional in 2009, replacing the Monopolies and Restrictive Trade Practices Commission (MRTPC), with powers to investigate mergers, monopolies, and unfair business practices. The CCI plays a key role in regulating market competition and ensuring a level playing field for businesses.
Bilakhia Group
The Bilakhia Group is an Indian conglomerate with diversified business interests, including textiles, chemicals, real estate, and education. Founded by the Bilakhia family, the group has grown over the years with a focus on innovation and community development. While not a cultural site, it plays a significant role in India’s industrial and economic landscape.
MyVal Transcatheter Heart Valve (THV)
The **MyVal Transcatheter Heart Valve (THV)** is an innovative medical device designed for minimally invasive treatment of severe aortic valve disease, such as aortic stenosis. Developed by Meril Life Sciences, it is a next-generation transcatheter aortic valve replacement (TAVR) system, offering improved flexibility and precision for patients at high surgical risk. Its design builds upon advancements in cardiac technology, providing a less invasive alternative to traditional open-heart surgery.
MyClip TEER system
The **MyClip TEER system** is an innovative digital platform designed to streamline and enhance the efficiency of TEER (Transcatheter Edge-to-Edge Repair) procedures in cardiology. It integrates advanced imaging and real-time data analysis to assist medical professionals in performing mitral valve repairs with greater precision. Developed to improve patient outcomes, the system reflects advancements in minimally invasive cardiac interventions. (Note: If “MyClip TEER” refers to a specific cultural or historical site, additional context would be needed for a more accurate summary.)
MISSO surgical robotic system
The **MISSO surgical robotic system** is a cutting-edge robotic-assisted platform designed for minimally invasive surgeries, enhancing precision and reducing recovery times. Developed by Chinese company **Surgerii Technology**, MISSO represents China’s advancements in medical robotics, aiming to compete with global systems like the *da Vinci Surgical System*. Its history reflects China’s growing focus on high-tech medical innovations to improve surgical outcomes and accessibility.
